Duncker Streett & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-95
| Closed | -$11.3K | – | 496 |
|
|
2024
Q2 | $11.3K | Hold |
95
| – | – | ﹤0.01% | 408 |
|
|
2024
Q1 | $10.1K | Hold |
95
| – | – | ﹤0.01% | 412 |
|
|
2023
Q4 | $9.45K | Sell |
95
-55
| -37% | -$5.47K | ﹤0.01% | 415 |
|
|
2023
Q3 | $15.5K | Sell |
150
-70
| -32% | -$7.23K | ﹤0.01% | 380 |
|
|
2023
Q2 | $26.7K | Hold |
220
| – | – | 0.01% | 340 |
|
|
2023
Q1 | $33.8K | Hold |
220
| – | – | 0.01% | 321 |
|
|
2022
Q4 | $39.5K | Hold |
220
| – | – | 0.01% | 315 |
|
|
2022
Q3 | $26K | Sell |
220
-1,400
| -86% | -$165K | 0.01% | 335 |
|
|
2022
Q2 | $231K | Hold |
1,620
| – | – | 0.06% | 206 |
|
|
2022
Q1 | $279K | Buy |
1,620
+1,200
| +286% | +$207K | 0.06% | 209 |
|
|
2021
Q4 | $107K | Sell |
420
-175
| -29% | -$44.6K | 0.02% | 288 |
|
|
2021
Q3 | $229K | Hold |
595
| – | – | 0.04% | 222 |
|
|
2021
Q2 | $140K | Hold |
595
| – | – | 0.03% | 263 |
|
|
2021
Q1 | $78K | Buy |
595
+75
| +14% | +$9.83K | 0.01% | 304 |
|
|
2020
Q4 | $54K | Buy |
520
+465
| +845% | +$48.3K | 0.01% | 331 |
|
|
2020
Q3 | $4K | Buy |
+55
| New | +$4K | ﹤0.01% | 468 |
|